ES526869A0 - Un procedimiento para la preparacion de un derivado de pirazol - Google Patents
Un procedimiento para la preparacion de un derivado de pirazolInfo
- Publication number
- ES526869A0 ES526869A0 ES526869A ES526869A ES526869A0 ES 526869 A0 ES526869 A0 ES 526869A0 ES 526869 A ES526869 A ES 526869A ES 526869 A ES526869 A ES 526869A ES 526869 A0 ES526869 A0 ES 526869A0
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- preparation
- pyrazole derivative
- pyrazole
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/16—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/437,994 US4495195A (en) | 1982-11-01 | 1982-11-01 | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8601900A1 ES8601900A1 (es) | 1985-05-01 |
ES526869A0 true ES526869A0 (es) | 1985-05-01 |
Family
ID=23738785
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526869A Granted ES526869A0 (es) | 1982-11-01 | 1983-10-28 | Un procedimiento para la preparacion de un derivado de pirazol |
Country Status (13)
Country | Link |
---|---|
US (1) | US4495195A (es) |
EP (1) | EP0112623A2 (es) |
JP (1) | JPS5995272A (es) |
KR (1) | KR840006629A (es) |
AU (1) | AU2068583A (es) |
DD (1) | DD210265A5 (es) |
DK (1) | DK492783D0 (es) |
ES (1) | ES526869A0 (es) |
FI (1) | FI833931A (es) |
GB (1) | GB2130205A (es) |
GR (1) | GR79640B (es) |
IL (1) | IL70075A0 (es) |
PT (1) | PT77583B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ208555A (en) * | 1983-06-23 | 1987-06-30 | American Cyanamid Co | (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives |
IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
JPS6425763A (en) | 1987-04-24 | 1989-01-27 | Mitsubishi Chem Ind | Pyrazoles and insecticide and acaricide containing said pyrazoles as active ingredient |
US4861777A (en) * | 1987-09-11 | 1989-08-29 | Mitsubishi Kasei Corporation | Pyrazole derivative and insecticidal and miticidal composition containing the derivative as active ingredient |
JP2751309B2 (ja) * | 1988-02-16 | 1998-05-18 | 三菱化学株式会社 | ピラゾール類およびこれを有効成分とする殺虫、殺ダニ、殺菌剤 |
JP2784925B2 (ja) * | 1988-09-07 | 1998-08-13 | 日本農薬株式会社 | 3又は5−フェニルピラゾール類又はその塩及び除草剤 |
CA2036192A1 (en) | 1990-02-13 | 1991-08-14 | Nicholas Meanwell | Heterocyclic carboxylic acids and esters |
US4956379A (en) * | 1990-02-13 | 1990-09-11 | Bristol-Myers Squibb Company | Pyrazole carboxylic acids and esters and inhibition of blood platelet aggregation therewith |
FR2665898B1 (fr) * | 1990-08-20 | 1994-03-11 | Sanofi | Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant. |
US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
GB9312853D0 (en) * | 1993-06-22 | 1993-08-04 | Euro Celtique Sa | Chemical compounds |
US5591776A (en) * | 1994-06-24 | 1997-01-07 | Euro-Celtique, S.A. | Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV |
HRP950330A2 (en) * | 1994-07-05 | 1997-10-31 | Ciba Geigy Ag | New herbicides |
ATE247655T1 (de) * | 1994-12-13 | 2003-09-15 | Euro Celtique Sa | Dreifachsubstituierte thioxanthine |
US6025361A (en) * | 1994-12-13 | 2000-02-15 | Euro-Celtique, S.A. | Trisubstituted thioxanthines |
DE69531506T2 (de) * | 1994-12-13 | 2004-06-24 | Euroceltique S.A. | Arylthioxanthine |
US6166041A (en) * | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
US6075016A (en) * | 1996-04-10 | 2000-06-13 | Euro-Celtique S.A. | 6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity |
ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
US5723608A (en) * | 1996-12-31 | 1998-03-03 | Neurogen Corporation | 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands |
WO1999024038A1 (en) | 1997-11-07 | 1999-05-20 | Johns Hopkins University | Methods for treatment of disorders of cardiac contractility |
WO2006022375A1 (ja) * | 2004-08-27 | 2006-03-02 | Astellas Pharma Inc. | 2-フェニルチオフェン誘導体 |
WO2006022374A1 (ja) * | 2004-08-27 | 2006-03-02 | Astellas Pharma Inc. | 2-フェニルピリジン誘導体 |
DE602006018635D1 (de) | 2005-10-07 | 2011-01-13 | Astellas Pharma Inc | Triarylcarbonsäurederivat |
EP1992361B1 (en) | 2006-02-24 | 2012-05-02 | Astellas Pharma Inc. | Remedy or preventive for digestive ulcer |
CN102333765B (zh) | 2009-02-27 | 2015-01-14 | 帝人制药株式会社 | 基于使用过渡金属催化剂的偶联法的苯基取代杂环衍生物的制造方法 |
SG187843A1 (en) | 2010-08-27 | 2013-03-28 | Teijin Pharma Ltd | Method for producing phenyl-substituted heterocyclic derivative by means of coupling method using a palladium compound |
EP2980085B1 (en) | 2013-03-29 | 2018-03-14 | Teijin Pharma Limited | Pyrazole derivative |
EP2944635B1 (en) * | 2014-05-15 | 2018-11-28 | Council of Scientific & Industrial Research | Pyrazole linked benzimidazole conjugates and a process for preparation thereof |
CN106632245B (zh) * | 2016-09-30 | 2019-11-15 | 华南理工大学 | 氮取代基苯基吡唑类黄嘌呤氧化还原酶抑制剂及制备与应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1261124B (de) * | 1961-09-22 | 1968-02-15 | Hoechst Ag | Verfahren zur Herstellung von Pyrazolen |
IT1053661B (it) * | 1966-09-27 | 1981-10-10 | Farmacosmici S P A | Ammidi dell acido 3 5 metil 5 3 pirazol carbossilico |
FR2104931B1 (es) * | 1970-09-08 | 1975-01-10 | Ferlux | |
DE2508934A1 (de) * | 1974-03-04 | 1975-09-11 | Byk Gulden Lomberg Chem Fab | Neue substituierte 5-amino-4- formyl-carbamoyl-pyrazole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
DE2410653A1 (de) * | 1974-03-06 | 1975-10-30 | Byk Gulden Lomberg Chem Fab | Neue heterocyclisch substituierte 5amino-4-formylcarbamoyl-pyrazole, verfahren zu ihrer herstellung und sie enthaltende arzneimittel |
US3899508A (en) * | 1974-04-12 | 1975-08-12 | Lilly Co Eli | 5-(2-Aminophenyl)pyrazole-3-carboxylic acids and esters thereof |
US3895027A (en) * | 1974-04-12 | 1975-07-15 | Lilly Co Eli | Process for preparing pyrazole-3-carboxylic acids |
US3903106A (en) * | 1974-04-12 | 1975-09-02 | Lilly Co Eli | Pyrazole-3-carboxylic acids |
FR2353292A1 (fr) * | 1975-08-05 | 1977-12-30 | Sogeras | Nouveaux derives du benzoyl-3 pyrazole |
FR2320093A1 (fr) * | 1975-08-05 | 1977-03-04 | Sogeras | Nouveaux acides diphenyl-pyrazole-5-acetiques |
US4134987A (en) * | 1976-01-14 | 1979-01-16 | Huppatz John L | Compounds and compositions |
US4214090A (en) * | 1976-01-14 | 1980-07-22 | Commonwealth Scientific And Industrial Research Organization | Fungicidal carboxamidopyrazoles |
US4245106A (en) * | 1979-07-05 | 1981-01-13 | Monsanto Company | Process for the preparation of 1-alkyl-3-aryl-4-pyrazolecarboxylates |
US4346097A (en) * | 1980-09-30 | 1982-08-24 | Warner-Lambert Company | Method for treating convulsions with pyrazole-4-carboxamide derivatives |
-
1982
- 1982-11-01 US US06/437,994 patent/US4495195A/en not_active Expired - Fee Related
-
1983
- 1983-10-26 GR GR72796A patent/GR79640B/el unknown
- 1983-10-27 GB GB08328755A patent/GB2130205A/en not_active Withdrawn
- 1983-10-27 FI FI833931A patent/FI833931A/fi not_active Application Discontinuation
- 1983-10-27 IL IL70075A patent/IL70075A0/xx unknown
- 1983-10-27 DK DK4927/83A patent/DK492783D0/da not_active Application Discontinuation
- 1983-10-27 EP EP83306530A patent/EP0112623A2/en not_active Withdrawn
- 1983-10-28 JP JP58203575A patent/JPS5995272A/ja active Pending
- 1983-10-28 ES ES526869A patent/ES526869A0/es active Granted
- 1983-10-28 DD DD83256094A patent/DD210265A5/de unknown
- 1983-10-28 AU AU20685/83A patent/AU2068583A/en not_active Abandoned
- 1983-10-28 PT PT77583A patent/PT77583B/pt unknown
- 1983-10-28 KR KR1019830005109A patent/KR840006629A/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK492783D0 (da) | 1983-10-27 |
EP0112623A2 (en) | 1984-07-04 |
PT77583A (en) | 1983-11-01 |
KR840006629A (ko) | 1984-12-01 |
AU2068583A (en) | 1984-05-10 |
JPS5995272A (ja) | 1984-06-01 |
GB8328755D0 (en) | 1983-11-30 |
ES8601900A1 (es) | 1985-05-01 |
US4495195A (en) | 1985-01-22 |
DD210265A5 (de) | 1984-06-06 |
GB2130205A (en) | 1984-05-31 |
PT77583B (en) | 1986-05-27 |
IL70075A0 (en) | 1984-01-31 |
GR79640B (es) | 1984-10-31 |
FI833931A (fi) | 1984-05-02 |
FI833931A0 (fi) | 1983-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES526869A0 (es) | Un procedimiento para la preparacion de un derivado de pirazol | |
ES530714A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo | |
ES505517A0 (es) | Un procedimiento para la preparacion de un derivado de n- arilbenzamida | |
ES504103A0 (es) | Un procedimiento para la preparacion de derivados de hidan- toina | |
ES505950A0 (es) | Un procedimiento para la preparacion de un derivado de tia- zol | |
ES548672A0 (es) | Un procedimiento para la preparacion de un derivado de dihi-dropiridina | |
ES526295A0 (es) | Un procedimiento para la preparacion de derivados de 1-normon-2-ilo | |
ES505678A0 (es) | Un procedimiento para la preparacion de un derivado de 3- aril-5-isotiazol | |
ES502994A0 (es) | Un procedimiento para la preparacion de derivados de pirazo-lopiridacina | |
ES502792A0 (es) | Un procedimiento para la preparacion de derivados de imida- zol | |
ES531659A0 (es) | Un procedimiento para la preparacion de nuevos derivados de arilamida | |
ES535980A0 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina | |
ES499559A0 (es) | Un procedimiento para la preparacion de derivados de pirrol | |
ES524399A0 (es) | Un procedimiento para la preparacion de derivados de milbenicina d | |
ES546905A0 (es) | Un procedimiento para la preparacion de derivados de pirazol | |
ES530669A0 (es) | Un procedimiento para la preparacion de nuevos derivados de fosfolipidos | |
ES536982A0 (es) | Un procedimiento para la preparacion de un derivado de carbostirilo | |
ES504764A0 (es) | Un procedimiento para la preparacion de un derivado 2-tiope-nem | |
ES504376A0 (es) | Un procedimiento para la preparacion de un derivado de fene-tilamina | |
ES540345A0 (es) | Un procedimiento para la preparacion de derivados de piperi-dina | |
ES527804A0 (es) | Un procedimiento para la preparacion de derivados de oxacefalosporina | |
ES500911A0 (es) | Un procedimiento para la preparacion de derivados de ergoli-na | |
ES541840A0 (es) | Un procedimiento para la preparacion de un derivado de imi- dazolilo | |
ES527232A0 (es) | Un procedimiento para la preparacion de nuevos derivados de triazol | |
ES498145A0 (es) | Un procedimiento para la preparacion de derivados de metoxi-cefalosporinas |